COXFA4L2 and cancer: NDUFA4L2 was aberrantly expressed in multiple types of cancer, including malignant hepatocellular carcinoma (Lai et al., 2016), colorectal cancer (Lv et al., 2016), ccRCC (Lv et al., 2016).